Effects of MCI-176, 2-(2, 5-dimethoxyphenylmethyl)-3-(2-dimethylaminoethyl)-6-isopropoxy-4 (3H )-quinazolinone hydrochloride, on coronary and aortic blood flows, mean blood pressure and heart rate were investigated in comparison with those of diltiazem in anesthetized dogs. MCI-176, like diltiazem, dose-dependently increased coronary and aortic blood flows and decreased mean blood pressure. In producing these effect MCI-176 was slightly but significantly more potent than diltiazem. Heart rate tended to increase with MCI-176, whereas it tended to decrease with diltiazem.
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Effects of MCI-176, 2-(2, 5-dimethoxyphenylmethyl)-3-(2-dimethylaminoethyl)-6-isopropoxy-4 (3H )-quinazolinone hydrochloride, on coronary and aortic blood flows, mean blood pressure and heart rate were investigated in comparison with those of diltiazem in anesthetized dogs. MCI-176, like diltiazem, dose-dependently increased coronary and aortic blood flows and decreased mean blood pressure. In producing these effect MCI-176 was slightly but significantly more potent than diltiazem. Heart rate tended to increase with MCI-176, whereas it tended to decrease with diltiazem.
MCI-176 ; calcium channel blocker ; coronary blood flow ; dog MCI-176, of which chemical structure is shown in Fig. 1 , is a new potent calcium channel Blocker selected from many quinazolinone derivatives (Sekiya et al. 1986*) . The present article reports preliminarily its effects on coronary flow and cardiohemodynamics in anesthetized dogs. Mongrel dogs of either sex weighing 9-15 kg were anesthetized with pentobarbital sodium 35 mg/kg, i.v. Under artificial respiration the chest was opened at the fourth intercostal space. Blood flows through the left circumflex coronary artery and ascending aorta were measured with non-cannulating type probes. Mean blood pressure was measured with an electromanometer at the femoral artery.
Heart rate was measured with a tachometer triggered by pulse pressures.
In 12 dogs, both MCI-176 and diltiazem (30 and 100 pg/kg i.v., respectively) were administered into the same animals.
The data obtained were analyzed by the paired t-test. The basal coronary and aortic blood flows, mean blood pressure and heart rate were 37+4 ml/min and 1.6+0.5 liter/min, 104+5 mm Hg, and 174+7 beats mm, respectively. As shown in Fig. 2 , MCI-176 increased coronary flow by 14.7 ml/min at 30 hg/kg and by 24.1 ml/min at 100 pg/kg. It increased aortic flow by 250 ml/min at 30 pg/kg and by 390 ml/min at 100 pg/kg and heart rage by 1.9 beats/ min at 30pg/kg and by 2.5 beats/min at 100pg/kg. MCI-176 decreased mean blood pressure by 19 mm Hg at 30 p g/kg and 25 mm Hg at 100 p g/kg. Essentially similar results were obtained with diltiazem, although heart rate tended to decrease with diltiazem. In producing these effects, however, MCI-176 was slightly but significantly (p <0.05) more potent than diltiazem. The coronary dilator effects of both drugs lasted about 4 min at 30 pg/kg and 8 min at 100pg/kg. The difference in potency between MCI-176 and diltiazem is thought to derive from the difference in calcium antagonistic potencies judging from the results obtained in our laboratory (unpublished observations). obtained were analyzed by the paired t-test. The basal coronary and aortic blood flows, mean blood pressure and heart rate were 37+4 ml/min and 1.6+0.5 liter/min, 104+5 mm Hg, and 174+7 beats mm, respectively. As shown in Fig. 2 , MCI-176 increased coronary flow by 14.7 ml/min at 30 hg/kg and by 24.1 ml/min at 100 pg/kg. It increased aortic flow by 250 ml/min at 30 pg/kg and by 390 ml/min at 100 pg/kg and heart rage by 1.9 beats/ min at 30pg/kg and by 2.5 beats/min at 100pg/kg. MCI-176 decreased mean blood pressure by 19 mm Hg at 30 p g/kg and 25 mm Hg at 100 p g/kg. Essentially similar results were obtained with diltiazem, although heart rate tended to decrease with diltiazem. In producing these effects, however, MCI-176 was slightly but significantly (p <0.05) more potent than diltiazem. The coronary dilator effects of both drugs lasted about 4 min at 30 pg/kg and 8 min at 100pg/kg. The difference in potency between MCI-176 and diltiazem is thought to derive from the difference in calcium antagonistic potencies judging from the results obtained in our laboratory (unpublished observations). 
